FDA Drug Application (022141) for LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE by MATRIX LABS

Back to FDA Applications sponsored by MATRIX LABS

Application Number022141
Product Number001
FormTABLET; ORAL
Dosage300MG; 300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Active IngredientLAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE



Back to FDA Applications sponsored by MATRIX LABS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.